LPL Financial
ASND icon

LPL Financial’s Ascendis Pharma A/S ASND Stock Holding History

LPL Financial’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.41M Buy
23,729
+9,384
+65% +$2.38M ﹤0.01% 2760
2026
Q2 		$3.83M Sell
14,345
-834
-5% -$195K ﹤0.01% 3051
2026
Q1 		$3.47M Buy
15,179
+1,048
+7% +$235K ﹤0.01% 2962
2025
Q4 		$3.01M Buy
14,131
+4,277
+43% +$883K ﹤0.01% 3012
2025
Q3 		$1.96M Buy
9,854
+2,587
+36% +$483K ﹤0.01% 3331
2025
Q2 		$1.25M Buy
7,267
+3,787
+109% +$617K ﹤0.01% 3544
2025
Q1 		$542K Sell
3,480
-719
-17% -$103K ﹤0.01% 4100
2024
Q4 		$578K Buy
4,199
+1,577
+60% +$207K ﹤0.01% 3966
2024
Q3 		$391K Sell
2,622
-252
-9% -$34K ﹤0.01% 4214
2024
Q2 		$392K Buy
2,874
+296
+11% +$40.3K ﹤0.01% 4066
2024
Q1 		$390K Sell
2,578
-276
-10% -$39.4K ﹤0.01% 3989
2023
Q4 		$359K Sell
2,854
-382
-12% -$38.1K ﹤0.01% 3940
2023
Q3 		$303K Sell
3,236
-597
-16% -$55.9K ﹤0.01% 3914
2023
Q2 		$342K Buy
+3,833
New +$334K ﹤0.01% 3739
2023
Q1 		– Sell
-1,736
Closed -$212K – 4488
2022
Q4 		$212K Buy
+1,736
New +$202K ﹤0.01% 3931
2022
Q3 		– Sell
-2,288
Closed -$213K – 4419
2022
Q2 		$213K Sell
2,288
-55
-2% -$5.18K ﹤0.01% 3893
2022
Q1 		$275K Sell
2,343
-393
-14% -$45.5K ﹤0.01% 3629
2021
Q4 		$368K Buy
2,736
+555
+25% +$82.6K ﹤0.01% 3539
2021
Q3 		$348K Sell
2,181
-117
-5% -$16K ﹤0.01% 3528
2021
Q2 		$302K Buy
2,298
+25
+1% +$3.33K ﹤0.01% 3580
2021
Q1 		$293K Sell
2,273
-50
-2% -$7.6K ﹤0.01% 3478
2020
Q4 		$387K Sell
2,323
-206
-8% -$34.1K ﹤0.01% 2979
2020
Q3 		$390K Buy
2,529
+21
+0.8% +$3.02K ﹤0.01% 2683
2020
Q2 		$371K Sell
2,508
-10
-0.4% -$1.37K ﹤0.01% 2667
2020
Q1 		$284K Buy
+2,518
New +$327K ﹤0.01% 2541
2019
Q3 		– Sell
-2,233
Closed -$257K – 3295
2019
Q2 		$257K Buy
2,233
+131
+6% +$15.7K ﹤0.01% 2827
2019
Q1 		$247K Buy
+2,102
New +$184K ﹤0.01% 2785

Other funds holding ASND

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 42.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $54.9B AUM 27.38% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

LPL Financial's ASND Position: Q3 2026 in Review

LPL Financial increased its Ascendis Pharma A/S (ASND) stake by 65% in Q3 2026, buying an estimated $2.38M and bringing the position to 23,729 shares worth $5.41M. The position accounts for ﹤0.01% of the portfolio, ranked #2760.

LPL Financial first reported a position in ASND in Q1 2019 and has held it in 27 quarters since. 235 funds tracked by Wall St. Rank hold ASND as of Q3 2026.

  • LPL Financial held 23,729 shares of Ascendis Pharma A/S worth $5.41M as of Q3 2026.
  • LPL Financial bought 9,384 Ascendis Pharma A/S shares in Q3 2026, an estimated $2.38M.
  • Ascendis Pharma A/S made up ﹤0.01% of LPL Financial's portfolio in Q3 2026, its #2760 holding.
  • LPL Financial first reported a position in Ascendis Pharma A/S in Q1 2019 and has held it in 27 quarters since.
  • 235 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2026.

Based on LPL Financial's 13F filing for Q3 2026, filed 6 Nov 2026.